Show simple item record

dc.contributor.authorHall, T
dc.contributor.authorStanton, T
dc.contributor.authorWang, WYS
dc.contributor.authorNg, ACT
dc.date.accessioned2022-01-25T10:13:55Z
dc.date.available2022-01-25T10:13:55Z
dc.date.issued2013
dc.identifier.issn0031-0808en_US
dc.identifier.urihttp://hdl.handle.net/10072/411746
dc.description.abstractStroke attributed to atrial fibrillation (AF) confers significant morbidity and mortality. In the past, warfarin has been the only successful stroke prevention agent available. However, it is often underutilized due to its well-known limitations, leaving many patients without adequate stroke protection. The last decade has seen significant strides forward in the field of anticoagulation for AF. The development of several novel oral anticoagulants that have superior efficacy, improved safety profile and fixed doses without the need for regular monitoring make them favorable as viable alternatives to warfarin. Improved risk scoring systems for both thrombembolism and bleeding have also allowed clinicians to better target patients most likely to benefit from these new therapies. In addition, non-pharmacological approaches to stroke prevention such as left atrial appendage exclusion devices may be useful in patients whom anticoagulation therapy is contraindicated. These new pharmacological and non-pharmacological options for stroke prevention in AF permit clinicians to tailor their management of patients according to individual needs and characteristics. The present review aims to outline the latest up-to-date management of AF in stroke prevention.en_US
dc.description.peerreviewedYesen_US
dc.languageengen_US
dc.publisherEdizioni Minerva Medicaen_US
dc.publisher.urihttps://www.minervamedica.it/en/journals/panminerva-medica/article.php?cod=R41Y2013N01A0043en_US
dc.relation.ispartofpagefrom43en_US
dc.relation.ispartofpageto58en_US
dc.relation.ispartofissue1en_US
dc.relation.ispartofjournalPanminerva Medicaen_US
dc.relation.ispartofvolume55en_US
dc.titleStroke prevention in atrial fibrillation: An update on current management strategiesen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationHall, T; Stanton, T; Wang, WYS; Ng, ACT, Stroke prevention in atrial fibrillation: An update on current management strategies, Panminerva Medica, 2013, 55 (1), pp. 43-58en_US
dc.date.updated2022-01-25T10:13:07Z
gro.hasfulltextNo Full Text
gro.griffith.authorStanton, Tony


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record